SEC Form 4 · accession 0000904454-18-000581
uniQure N.V. · QURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Gut
Officer — Chief Medical Officer
Period of report
Sep 18, 2018
Accepted (ET)
Sep 25, 2018 · 1:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590560
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Sep 18, 2018 | A | 35,000 | $0.00 | A | 35,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $39.97 | Sep 18, 2018 | A | 70,000 | A | — | Sep 18, 2028 | Ordinary Shares | 70,000 | 70,000 | D |
Explanation of responses
- F1Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in thirds on the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.
- F2The Stock Option vests over four years, with 25% vesting after twelve months from the date of grant and then 6.25% every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date.